Development of a self-inactivating lentivirus vector

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 8150-5157

  Miyoshi, Hiroyuki ^a   Blömer, Ulrike ^a,b   Takahashi, Masayo ^a,c   Gage, Fred H ^a   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1; VIRUS VECTOR;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CYTOMEGALOVIRUS; FEMALE; GENE DELETION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROVIRUS; RAT; TATA BOX; TRANSCRIPTION REGULATION; VIRUS INACTIVATION;

EID: 0031666744     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.8150-8157.1998     Document Type: Article

References (56)

1. Armentano, D., S.-F. Yu, P. W. Kantoff, T. V. Ruden, W. F. Anderson, and E. Gilboa. 1987. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1647-1650.
2. Berkhout, B., A. Gatignol, A. B. Rabson, and K.-T. Jeang. 1990. TAR-independent activation of the HlV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 62:757-767.
3. Berkhout, B., and K.-T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
4. Blömer, U., L. Naldini, T. Kafri, D. Trono, I. M. Verma, and F. H. Gage. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:6641-6649.
5. Bowtell, D. D. L., S. Cory, G. R. Johnson, and T. J. Gonda. 1988. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J. Virol. 62:2464-2473.
6. Brown, P. H., L. S. Tiley, and B. R. Cullen. 1991. Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J. Virol. 65:3340-3343.
7. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89:6580-6584.
8. Cherrington, J., and D. Ganem. 1992. Regulation of polyadenylation in human immunodeficiency virus (HIV): contribution of promoter proximity and upstream sequences. EMBO J. 11:1513-1524.
9. Cone, R. D., A. Weber-Benarous, D. Baorto, and R. C. Mulligan. 1987. Regulated expression of a complete human β-globin gene encoded by a transmissible retrovirus vector. Mol. Cell. Biol. 7:887-897.
10. Corboy, J. R., J. M. Buzy, M. C. Zink, and J. E. Clements. 1992. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258:1804-1808.
11. Correll, P. H., S. Colilla, and S. Karlsson. 1994. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 84:1812-1822.
12. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
13. DeZazzo, J. D., J. E. Kilpatrick, and M. J. Imperiale. 1991. Involvement of long terminal repeat U3 sequences overlapping the transcription control region in human immunodeficiency virus type 1 mRNA 3′ end formation. Mol. Cell. Biol. 11:1624-1630.
14. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
15. Emerman, M., and H. M. Temin. 1986. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6:792-800.
16. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189-1193.
17. Garcia, J. A., F. K. Wu, R. Mitsuyasu, and R. B. Gaynor. 1987. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J. 6:3761-3770.
18. Gilmartin, G. M., E. S. Fleming, and J. Oetjen. 1992. Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR. EMBO J. 11:4419-4428.
19. Gilmartin, G. M., E. S. Fleming, J. Oetjen, and B. R. Graveley. 1995. CPSF recognition of an HIV-1 mRNA 3′-processing enhancer: multiple sequence contacts involved in poly(A) site definition. Genes Dev. 9:72-83.
20. Guild, B. C., M. H. Finer, D. E. Housman, and R. C. Mulligan. 1988. Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J. Virol. 62:3795-3801.
21. Hawley, R. G., L. Covarrubias, T. Hawley, and B. Mintz. 1987. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 84:2406-2410.
22. Jones, K. A., J. T. Kadonaga, P. A. Luciw, and R. Tjian. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232:755-759.
23. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
24. Kafri, T., U. Blömer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
25. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P. A. Baeuerle. 1994. Constitutive NF-kappa;B activity in neurons. Mol. Cell. Biol. 14:3981-3992.
26. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
27. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
28. Krug, R. M. 1993. The regulation of export of mRNA from nucleus to cytoplasm. Curr. Opin. Cell Biol. 5:944-949.
29. Leonard, J., C. Parrott, A. J. Buckler-White, W. Turner, E. K. Ross, M. A. Martin, and A. B. Rabson. 1989. The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919-4924.
30. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-3058.
31. Liu, J., N. D. Perkins, R. M. Schmid, and G. J. Nabel. 1992. Specific NF-κB subunits act in concert with tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887.
32. Miller, A. D. 1992. Human gene therapy comes of age. Nature 357:455-460.
33. Miyoshi, H., M. Takahashi, F. H. Gage, and I. M. Verma. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94:10319-10323.
34. Morgan, R. A., and W. F. Anderson. 1993. Human gene therapy. Annu. Rev. Biochem. 62:191-217.
35. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
36. Nable, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
37. Nabel, G. J., S. A. Rice, D. M. Knipe, and D. Baltimore. 1988. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239:1299-1302.
38. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
39. Naldini, L., U. Blömer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
40. Niswender, K. D., S. M. Blackman, L. Rohde, M. A. Magnuson, and D. W. Piston. 1995. Quantitative imaging of green fluorescent protein in cultured cells: comparison of microscopic techniques, use in fusion proteins and detection limits. J. Microsc. 180:109-116.
41. Olsen, H. S., and C. A. Rosen. 1992. Contribution of the TATA motif to tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597.
42. Rattner, A., M. Korner, M. D. Walker, and Y. Citri. 1993. NF-κB activates the HIV promoter in neurons. EMBO J. 12:4261-4267.
43. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
44. Ross, E. K., A. J. Buckler-White, A. B. Rabson, G. Englund, and M. A. Martin. 1991. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell type. J. Virol. 65:4350-4358.
45. Soriano, P., G. Friedrich, and P. Lawinger. 1991. Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 65:2314-2319.
46. Valsamakis, A., S. Zeichner, S. Carswell, and J. C. Alwine. 1991. The human immunodeficiency virus type 1 polyadenylation signal: a 3′ long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylation. Proc. Natl. Acad. Sci. USA 88:2108-2112.
47. Valsamakis, A., N. Schek, and J. C. Alwine. 1992. Elements upstream of the AAUAAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro. Mol. Cell. Biol. 12:3699-3705.
48. Verma, I. M., and N. Somia, 1997. Gene therapy - promises, problems and prospects. Nature 389:239-242.
49. Weinberg, J. B., T. J. Matthews, B. R. Cullen, and M. H. Malim. 1991. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1477-1482.
50. Williams, D. A., S. H. Orkin, and R. C. Mulligan. 1986. Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 83: 2566-2570.
51. Wu, Q., M. Chen, M. Buchwald, and R. A. Phillips. 1995. A simple, rapid method for isolation of high quality genomic DNA from animal tissues. Nucleic Acids Res. 23:5087-5088.
52. Xu, L., J.-K. Yee, J. A. Wolff, and T. Friedmann. 1989. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology 171:331-341.
53. Yee, J.-K., J. C. Moores, D. J. Jolly, J. A. Wolff, J. G. Respess, and T. Friedmann. 1987. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84:5197-5201.
54. Yu, S.-F., T. V. Rüden, P. W. Kantoff, C. Garber, M. Seiberg, U. Rüther, W. F. Anderson, E. F. Wagner, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.
55. Zeichner, S. L., J. Y. H. Kim, and J. C. Alwine. 1991. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 65:2436-2444.
56. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.